1 10 120 14-3-3 LIGAND PREVENTS NUCLEAR IMPORT OF C-ABL PROTEIN IN CHRONIC MYELOID LEUKEMIA. HERE WE DEMONSTRATED THAT THE 'LOSS OF FUNCTION' OF NOT-REARRANGED C-ABL IN CHRONIC MYELOID LEUKEMIA (CML) IS PROMOTED BY ITS CYTOPLASMIC COMPARTMENTALIZATION BOUND TO 14-3-3 SIGMA SCAFFOLDING PROTEIN. IN PARTICULAR, CONSTITUTIVE TYROSINE KINASE (TK) ACTIVITY OF P210 BCR-ABL BLOCKS C-JUN N-TERMINAL KINASE (JNK) PHOSPHORYLATION LEADING TO 14-3-3 SIGMA PHOSPHORYLATION AT A CRITICAL RESIDUE (SER(186)) FOR C-ABL BINDING IN RESPONSE TO DNA DAMAGE. MOREOVER, IT IS ASSOCIATED WITH 14-3-3 SIGMA OVER-EXPRESSION ARISING FROM EPIGENETIC MECHANISMS (PROMOTER HYPER-ACETYLATION). ACCORDINGLY, P210 BCR-ABL TK INHIBITION BY THE TK INHIBITOR IMATINIB MESYLATE (IM) EVOKES MULTIPLE EVENTS, INCLUDING JNK PHOSPHORYLATION AT THR(183), P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) PHOSPHORYLATION AT THR(180), C-ABL DE-PHOSPHORYLATION AT SER RESIDUES INVOLVED IN 14-3-3 BINDING AND REDUCTION OF 14-3-3 SIGMA EXPRESSION, THAT LET C-ABL RELEASE FROM 14-3-3 SIGMA AND NUCLEAR IMPORT, AND ADDRESS BCR-ABL-EXPRESSING CELLS TOWARDS APOPTOTIC DEATH. INFORMATIONAL SPECTRUM METHOD (ISM), A VIRTUAL SPECTROSCOPY METHOD FOR ANALYSIS OF PROTEIN INTERACTIONS BASED ON THEIR STRUCTURE, AND MATHEMATICAL FILTERING IN CROSS SPECTRUM (CS) ANALYSIS IDENTIFIED 14-3-3 SIGMA/C-ABL BINDING SITES. FURTHER INVESTIGATION ON CS PROFILES OF C-ABL- AND P210 BCR-ABL-CONTAINING COMPLEXES REVEALED THE MECHANISM LIKELY INVOLVED 14-3-3 PRECLUDED PHOSPHORYLATION IN CML CELLS. 2009 2 1884 22 ENDOCANNABINOID-EPIGENETIC CROSS-TALK: A BRIDGE TOWARD STRESS COPING. THERE IS NO ARGUMENT WITH REGARD TO THE PHYSICAL AND PSYCHOLOGICAL STRESS-RELATED NATURE OF NEUROPSYCHIATRIC DISORDERS. YET, THE MECHANISMS THAT FACILITATE DISEASE ONSET STARTING FROM MOLECULAR STRESS RESPONSES ARE ELUSIVE. ENVIRONMENTAL STRESS CHALLENGES INDIVIDUALS' EQUILIBRIUM, ENHANCING HOMEOSTATIC REQUEST IN THE ATTEMPT TO STEER DOWN AROUSAL-INSTRUMENTAL MOLECULAR PATHWAYS THAT UNDERLIE HYPERVIGILANCE AND ANXIETY. A RELEVANT HOMEOSTATIC PATHWAY IS THE ENDOCANNABINOID SYSTEM (ECS). IN THIS REVIEW, WE SUMMARIZE RECENT DISCOVERIES UNAMBIGUOUSLY LISTING ECS AS A STRESS COPING MECHANISM. AS STRESS EVOKES HUGE EXCITATORY RESPONSES IN EMOTIONAL-RELEVANT LIMBIC AREAS, THE ECS LIMITS GLUTAMATE RELEASE VIA 2-ARACHYDONILGLYCEROL (2-AG) STRESS-INDUCED SYNTHESIS AND RETROGRADE CANNABINOID 1 (CB1)-RECEPTOR ACTIVATION AT THE SYNAPSE. HOWEVER, ECS SHOWS INTRINSIC VULNERABILITY AS 2-AG OVERSTIMULATION BY CHRONIC STRESS RAPIDLY LEADS TO CB1-RECEPTOR DESENSITIZATION. IN THIS REVIEW, WE EMPHASIZE THE PROTECTIVE ROLE OF 2-AG IN STRESS-RESPONSE TERMINATION AND STRESS RESILIENCY. INTERESTINGLY, WE DISCUSS ECS REGULATION WITH A FURTHER NUCLEAR HOMEOSTATIC SYSTEM WHOSE NATURE IS EXQUISITELY EPIGENETIC, ORCHESTRATED BY LYSINE SPECIFIC DEMETHYLASE 1. WE HERE EMPHASIZE A REMARKABLE EXAMPLE OF STRESS-COPING NETWORK WHERE TRANSCRIPTIONAL HOMEOSTASIS SUBSERVES SYNAPTIC AND BEHAVIORAL ADAPTATION, AIMING AT REDUCING PSYCHIATRIC EFFECTS OF TRAUMATIC EXPERIENCES. 2020 3 1856 24 ELEVATION OF N-ACETYLTRANSFERASE 10 IN HIPPOCAMPAL NEURONS MEDIATES DEPRESSION- AND ANXIETY-LIKE BEHAVIORS. MAJOR DEPRESSIVE DISORDER (MDD) IS ONE OF THE MOST DEBILITATING AND SEVERE MENTAL DISEASES GLOBALLY. INCREASING EVIDENCE HAS SHOWN THAT EPIGENETICS IS CRITICAL FOR UNDERSTANDING BRAIN FUNCTION AND BRAIN DISORDERS, INCLUDING MDD. N-ACETYLTRANSFERASE 10 (NAT10), ACTING ON HISTONES, MRNA AND OTHER SUBSTRATES, HAS BEEN REPORTED TO BE INVOLVED IN EPIGENETIC EVENTS, INCLUDING HISTONE ACETYLATION AND MRNA MODIFICATIONS. NAT10 IS HIGHLY EXPRESSED IN THE BRAIN. HOWEVER, THE POTENTIAL EFFECTS OF NAT10 ON MDD ARE STILL UNKNOWN. HERE, WE EXPLOITED CHRONIC MILD STRESS (CMS) TO INDUCE ANXIETY- AND DEPRESSION-LIKE BEHAVIORS IN MICE AND FOUND THAT THE EXPRESSION OF NAT10 IN THE MOUSE HIPPOCAMPUS WAS UPREGULATED AFTER CMS TREATMENT. INHIBITION OF NAT10 BY PHARMACOLOGICAL METHODS PRODUCED ANXIOLYTIC- AND ANTIDEPRESSANT-LIKE EFFECTS. NEURON-SPECIFIC OVEREXPRESSION OF NAT10 IN THE HIPPOCAMPUS RESULTED IN ANXIETY- AND DEPRESSION-LIKE BEHAVIORS, ACCOMPANIED BY HIGHER SIRT1 PROTEIN LEVELS, AND LOWER DENDRITIC SPINE DENSITIES. OVERALL, IT WAS FOUND THAT ELEVATION OF NAT10 IN HIPPOCAMPAL NEURONS IS INVOLVED IN THE OCCURRENCE OF ANXIETY- AND DEPRESSION-LIKE BEHAVIORS, SUGGESTING THAT NAT10 COULD BE A POTENTIAL NEW TARGET FOR DEVELOPING ANXIOLYTICS AND ANTIDEPRESSANTS. 2022 4 6056 24 THE CYTIDINE N-ACETYLTRANSFERASE NAT10 PARTICIPATES IN PERIPHERAL NERVE INJURY-INDUCED NEUROPATHIC PAIN BY STABILIZING SYT9 EXPRESSION IN PRIMARY SENSORY NEURONS. RNA N4-ACETYLCYTIDINE (AC4C) MODIFICATION IS INCREASINGLY RECOGNIZED AS AN IMPORTANT LAYER OF GENE REGULATION; HOWEVER, THE INVOLVEMENT OF AC4C IN PAIN REGULATION HAS NOT BEEN STUDIED. HERE, WE REPORT THAT N-ACETYLTRANSFERASE 10 PROTEIN (NAT10; THE ONLY KNOWN AC4C "WRITER") CONTRIBUTES TO THE INDUCTION AND DEVELOPMENT OF NEUROPATHIC PAIN IN AN AC4C-DEPENDENT MANNER. PERIPHERAL NERVE INJURY INCREASES THE LEVELS OF NAT10 EXPRESSION AND OVERALL AC4C IN INJURED DORSAL ROOT GANGLIA (DRGS). THIS UPREGULATION IS TRIGGERED BY THE ACTIVATION OF UPSTREAM TRANSCRIPTION FACTOR 1 (USF1), A TRANSCRIPTION FACTOR THAT BINDS TO THE NAT10 PROMOTER. KNOCK-DOWN OR GENETIC DELETION OF NAT10 IN THE DRG ABOLISHES THE GAIN OF AC4C SITES IN SYT9 MRNA AND THE AUGMENTATION OF SYT9 PROTEIN, RESULTING IN A MARKED ANTINOCICEPTIVE EFFECT IN NERVE-INJURED MALE MICE. CONVERSELY, MIMICKING NAT10 UPREGULATION IN THE ABSENCE OF INJURY EVOKES THE ELEVATION OF SYT9 AC4C AND SYT9 PROTEIN AND INDUCES THE GENESIS OF NEUROPATHIC-PAIN-LIKE BEHAVIORS. THESE FINDINGS DEMONSTRATE THAT USF1-GOVERNED NAT10 REGULATES NEUROPATHIC PAIN BY TARGETING SYT9 AC4C IN PERIPHERAL NOCICEPTIVE SENSORY NEURONS. OUR FINDINGS ESTABLISH NAT10 AS A CRITICAL ENDOGENOUS INITIATOR OF NOCICEPTIVE BEHAVIOR AND A PROMISING NEW TARGET FOR TREATING NEUROPATHIC PAIN.SIGNIFICANCE STATEMENT THE CYTIDINE N4-ACETYLCYTIDINE (AC4C), A NEW EPIGENETIC RNA MODIFICATION, IS CRUCIAL FOR THE TRANSLATION AND STABILITY OF MRNA, BUT ITS ROLE FOR CHRONIC PAIN REMAINS UNCLEAR. HERE, WE DEMONSTRATE THAT N-ACETYLTRANSFERASE 10 (NAT10) ACTS AS AC4C N-ACETYLTRANSFERASE AND PLAYS AN IMPORTANT ROLE IN THE DEVELOPMENT AND MAINTENANCE OF NEUROPATHIC PAIN. NAT10 WAS UPREGULATED VIA THE ACTIVATION OF THE TRANSCRIPTION FACTOR UPSTREAM TRANSCRIPTION FACTOR 1 (USF1) IN THE INJURED DORSAL ROOT GANGLION (DRG) AFTER PERIPHERAL NERVE INJURY. SINCE PHARMACOLOGICAL OR GENETIC DELETING NAT10 IN THE DRG ATTENUATED THE NERVE INJURY-INDUCED NOCICEPTIVE HYPERSENSITIVITIES PARTIALLY THROUGH SUPPRESSING SYT9 MRNA AC4C AND STABILIZING SYT9 PROTEIN LEVEL, NAT10 MAY SERVE AS AN EFFECTIVE AND NOVEL THERAPEUTIC TARGET FOR NEUROPATHIC PAIN. 2023 5 5967 26 TERMINATION OF ACUTE STRESS RESPONSE BY THE ENDOCANNABINOID SYSTEM IS REGULATED THROUGH LYSINE-SPECIFIC DEMETHYLASE 1-MEDIATED TRANSCRIPTIONAL REPRESSION OF 2-AG HYDROLASES ABHD6 AND MAGL. ACUTE ENVIRONMENTAL STRESS RARELY IMPLIES LONG-LASTING NEUROPHYSIOLOGICAL AND BEHAVIORAL ALTERATIONS. ON THE CONTRARY, CHRONIC STRESS EXERTS A POTENT TOXIC EFFECT AT THE GLUTAMATERGIC SYNAPSE WHOSE ALTERED PHYSIOLOGY HAS BEEN RECOGNIZED AS A CORE TRAIT OF NEUROPSYCHIATRIC DISORDERS. THE ENDOCANNABINOID SYSTEM (ECS) PLAYS AN IMPORTANT ROLE IN THE HOMEOSTATIC RESPONSE TO ACUTE STRESS. IN PARTICULAR, STRESS INDUCES SYNTHESIS OF ENDOCANNABINOID (ECB) 2-ARACHIDONYL GLYCEROL (2-AG). 2-AG STIMULATES PRESYNAPTIC CANNABINOID 1 (CB1) RECEPTOR CONTRIBUTING TO STRESS RESPONSE TERMINATION THROUGH INHIBITION OF GLUTAMATE RELEASE, RESTRAINING THEREAFTER ANXIETY AROUSAL. WE EMPLOY MOUSE MODELS OF STRESS RESPONSE COUPLED TO GENE EXPRESSION ANALYSES, UNRAVELLING THAT IN RESPONSE TO ACUTE PSYCHOSOCIAL STRESS IN THE MOUSE HIPPOCAMPUS, ECS-MEDIATED SYNAPTIC MODULATION IS ENHANCED VIA TRANSCRIPTIONAL REPRESSION OF TWO ENZYMES INVOLVED IN 2-AG DEGRADATION: ALPHA/BETA-HYDROLASE DOMAIN CONTAINING 6 (ABHD6) AND MONOACYLGLYCEROL LIPASE (MAGL). SUCH A PROCESS IS ORCHESTRATED BY THE EPIGENETIC COREPRESSOR LSD1 WHO DIRECTLY INTERACTS WITH PROMOTER REGULATORY REGIONS OF ABHD6 AND MAGL. REMARKABLY, NEGATIVE TRANSCRIPTIONAL CONTROL OF ABHD6 AND MAGL IS LOST IN THE HIPPOCAMPUS UPON CHRONIC PSYCHOSOCIAL STRESS, POSSIBLY CONTRIBUTING TO TRAUMA-INDUCED DRIFT OF SYNAPSE PHYSIOLOGY TOWARD UNCONTROLLED GLUTAMATE TRANSMISSION. WE PREVIOUSLY SHOWED THAT IN MICE LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) INCREASES ITS HIPPOCAMPAL EXPRESSION IN RESPONSE TO PSYCHOSOCIAL STRESS PREVENTING EXCESSIVE CONSOLIDATION OF ANXIETY-RELATED PLASTICITY. IN THIS WORK, WE UNRAVEL A NODAL EPIGENETIC MODULATION OF ECB TURN OVER, SHEDDING NEW LIGHT ON THE MOLECULAR SUBSTRATE OF CONVERGING STRESS-TERMINATING EFFECTS DISPLAYED BY ECS AND LSD1. 2020 6 1761 20 EARLY STRESS EVOKES AGE-DEPENDENT BIPHASIC CHANGES IN HIPPOCAMPAL NEUROGENESIS, BDNF EXPRESSION, AND COGNITION. BACKGROUND: ADULT-ONSET STRESSORS EXERT OPPOSING EFFECTS ON HIPPOCAMPAL NEUROGENESIS AND COGNITION, WITH ENHANCEMENT OBSERVED FOLLOWING MILD STRESS AND DYSFUNCTION FOLLOWING SEVERE CHRONIC STRESS. WHILE EARLY LIFE STRESS EVOKES PERSISTENT CHANGES IN ANXIETY, IT IS UNKNOWN WHETHER EARLY STRESS DIFFERENTIALLY REGULATES HIPPOCAMPAL NEUROGENESIS, TROPHIC FACTOR EXPRESSION, AND COGNITION ACROSS THE LIFE SPAN. METHODS: HIPPOCAMPAL-DEPENDENT COGNITIVE BEHAVIOR, NEUROGENESIS, AND EPIGENETIC REGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) EXPRESSION WAS EXAMINED AT DISTINCT TIME POINTS ACROSS THE LIFE SPAN IN RATS SUBJECTED TO THE EARLY STRESS OF MATERNAL SEPARATION (ES) AND CONTROL GROUPS. WE ALSO EXAMINED THE INFLUENCE OF CHRONIC ANTIDEPRESSANT TREATMENT ON THE NEUROGENIC, NEUROTROPHIC, AND COGNITIVE CHANGES IN MIDDLE-AGED ES ANIMALS. RESULTS: ANIMALS SUBJECTED TO EARLY STRESS OF MATERNAL SEPARATION EXAMINED DURING POSTNATAL LIFE AND YOUNG ADULTHOOD EXHIBITED ENHANCED HIPPOCAMPAL NEUROGENESIS, DECREASED REPRESSIVE HISTONE METHYLATION AT THE BDNF IV PROMOTER ALONG WITH ENHANCED BDNF LEVELS, AND IMPROVED PERFORMANCE ON THE STRESS-ASSOCIATED MORRIS WATER MAZE. STRIKINGLY, OPPOSING CHANGES IN HIPPOCAMPAL NEUROGENESIS AND EPIGENETIC REGULATION OF BDNF IV EXPRESSION, CONCOMITANT WITH IMPAIRMENTS ON HIPPOCAMPAL-DEPENDENT COGNITIVE TASKS, WERE OBSERVED IN MIDDLE-AGED ES ANIMALS. CHRONIC ANTIDEPRESSANT TREATMENT WITH AMITRIPTYLINE ATTENUATED THE MALADAPTIVE NEUROGENIC, EPIGENETIC, TRANSCRIPTIONAL, AND COGNITIVE EFFECTS IN MIDDLE-AGED ES ANIMALS. CONCLUSIONS: OUR STUDY PROVIDES NOVEL INSIGHTS INTO THE SHORT- AND LONG-TERM CONSEQUENCES OF ES, DEMONSTRATING BOTH BIPHASIC AND UNIQUE, AGE-DEPENDENT CHANGES AT THE MOLECULAR, EPIGENETIC, NEUROGENIC, AND BEHAVIORAL LEVELS. THESE RESULTS INDICATE THAT EARLY STRESS MAY TRANSIENTLY ENDOW ANIMALS WITH A POTENTIAL ADAPTIVE ADVANTAGE IN STRESSFUL ENVIRONMENTS BUT ACROSS A LIFE SPAN IS ASSOCIATED WITH LONG-TERM DELETERIOUS EFFECTS. 2013 7 213 22 ACUTE AND CHRONIC ELECTROCONVULSIVE SEIZURES (ECS) DIFFERENTIALLY REGULATE THE EXPRESSION OF EPIGENETIC MACHINERY IN THE ADULT RAT HIPPOCAMPUS. BACKGROUND: ELECTROCONVULSIVE SEIZURE TREATMENT IS A FAST-ACTING ANTIDEPRESSANT THERAPY THAT EVOKES RAPID TRANSCRIPTIONAL, NEUROGENIC, AND BEHAVIORAL CHANGES. EPIGENETIC MECHANISMS CONTRIBUTE TO ALTERED GENE REGULATION, WHICH UNDERLIES THE NEUROGENIC AND BEHAVIORAL EFFECTS OF ELECTROCONVULSIVE SEIZURE. WE HYPOTHESIZED THAT ELECTROCONVULSIVE SEIZURE MAY MODULATE THE EXPRESSION OF EPIGENETIC MACHINERY, THUS ESTABLISHING POTENTIAL ALTERATIONS IN THE EPIGENETIC LANDSCAPE. METHODS: WE EXAMINED THE INFLUENCE OF ACUTE AND CHRONIC ELECTROCONVULSIVE SEIZURE ON THE GENE EXPRESSION OF HISTONE MODIFIERS, NAMELY HISTONE ACETYLTRANSFERASES, HISTONE DEACETYLASES, HISTONE METHYLTRANSFERASES, AND HISTONE (LYSINE) DEMETHYLASES AS WELL AS DNA MODIFYING ENZYMES, INCLUDING DNA METHYLTRANSFERASES, DNA DEMETHYLASES, AND METHYL-CPG-BINDING PROTEINS IN THE HIPPOCAMPI OF ADULT MALE WISTAR RATS USING QUANTITATIVE REAL TIME-PCR ANALYSIS. FURTHER, WE EXAMINED THE INFLUENCE OF ACUTE AND CHRONIC ELECTROCONVULSIVE SEIZURE ON GLOBAL AND RESIDUE-SPECIFIC HISTONE ACETYLATION AND METHYLATION LEVELS WITHIN THE HIPPOCAMPUS, A BRAIN REGION IMPLICATED IN THE CELLULAR AND BEHAVIORAL EFFECTS OF ELECTROCONVULSIVE SEIZURE. RESULTS: ACUTE AND CHRONIC ELECTROCONVULSIVE SEIZURE INDUCED A PRIMARILY UNIQUE, AND IN CERTAIN CASES BIDIRECTIONAL, REGULATION OF HISTONE AND DNA MODIFIERS, AND METHYL-CPG-BINDING PROTEINS, WITH AN OVERLAPPING PATTERN OF GENE REGULATION RESTRICTED TO SIRT4, MLL3, JMJD3, GADD45B, TET2, AND TET3. GLOBAL HISTONE ACETYLATION AND METHYLATION LEVELS WERE PREDOMINANTLY UNCHANGED, WITH THE EXCEPTION OF A SIGNIFICANT DECLINE IN H3K9 ACETYLATION IN THE HIPPOCAMPUS FOLLOWING CHRONIC ELECTROCONVULSIVE SEIZURE. CONCLUSIONS: ELECTROCONVULSIVE SEIZURE TREATMENT EVOKES THE TRANSCRIPTIONAL REGULATION OF SEVERAL HISTONE AND DNA MODIFIERS, AND METHYL-CPG-BINDING PROTEINS WITHIN THE HIPPOCAMPUS, WITH A PREDOMINANTLY DISTINCT PATTERN OF REGULATION INDUCED BY ACUTE AND CHRONIC ELECTROCONVULSIVE SEIZURE. 2016 8 4878 27 OVEREXPRESSION OF THE HISTONE DIMETHYLTRANSFERASE G9A IN NUCLEUS ACCUMBENS SHELL INCREASES COCAINE SELF-ADMINISTRATION, STRESS-INDUCED REINSTATEMENT, AND ANXIETY. REPEATED EXPOSURE TO COCAINE INDUCES LASTING EPIGENETIC CHANGES IN NEURONS THAT PROMOTE THE DEVELOPMENT AND PERSISTENCE OF ADDICTION. ONE EPIGENETIC ALTERATION INVOLVES REDUCTIONS IN LEVELS OF THE HISTONE DIMETHYLTRANSFERASE G9A IN NUCLEUS ACCUMBENS (NAC) AFTER CHRONIC COCAINE ADMINISTRATION. THIS REDUCTION IN G9A MAY ENHANCE COCAINE REWARD BECAUSE OVEREXPRESSING G9A IN THE NAC DECREASES COCAINE-CONDITIONED PLACE PREFERENCE. THEREFORE, WE HYPOTHESIZED THAT HSV-MEDIATED G9A OVEREXPRESSION IN THE NAC SHELL (NACSH) WOULD ATTENUATE COCAINE SELF-ADMINISTRATION (SA) AND COCAINE-SEEKING BEHAVIOR. INSTEAD, WE FOUND THAT G9A OVEREXPRESSION, AND THE RESULTING INCREASE IN HISTONE 3 LYSINE 9 DIMETHYLATION (H3K9ME2), INCREASES SENSITIVITY TO COCAINE REINFORCEMENT AND ENHANCES MOTIVATION FOR COCAINE IN SELF-ADMINISTERING MALE RATS. MOREOVER, WHEN G9A OVEREXPRESSION IS LIMITED TO THE INITIAL 15 D OF COCAINE SA TRAINING, IT PRODUCES AN ENDURING POSTEXPRESSION ENHANCEMENT IN COCAINE SA AND PROLONGED (OVER 5 WEEKS) INCREASES IN REINSTATEMENT OF COCAINE SEEKING INDUCED BY FOOT-SHOCK STRESS, BUT IN THE ABSENCE OF CONTINUED GLOBAL ELEVATIONS IN H3K9ME2. THE INCREASE IN STRESS-INDUCED REINSTATEMENT IS PARALLELED BY HEIGHTENED ANXIETY MEASURES, SUGGESTING THAT COUNTERING THE COCAINE-INDUCED DECREASES IN ENDOGENOUS G9A WITH ECTOPIC G9A OVEREXPRESSION LEADS TO LASTING ANXIOGENIC EFFECTS. FINALLY, WE FOUND AN ENDURING REDUCTION IN PHOSPHORYLATED CAMP-RESPONSE ELEMENT BINDING PROTEIN LEVELS IN THE NACSH THAT COULD ACCOUNT FOR THE INCREASED ANXIETY. THESE DATA DEMONSTRATE A NOVEL ROLE FOR G9A IN PROMOTING COMORBID COCAINE ADDICTION AND ANXIETY AND SUGGEST THAT INCREASED EPIGENETIC REPRESSION OF TRANSCRIPTION THROUGH H3K9 DURING COCAINE USE CAN HAVE LONG-LASTING AND UNEXPECTED NEGATIVE CONSEQUENCES ON BEHAVIOR.SIGNIFICANCE STATEMENT COCAINE ADDICTION IS A NEUROPSYCHIATRIC DISORDER THAT IS DETRIMENTAL TO SOCIETY AND CURRENTLY HAS NO EFFECTIVE TREATMENTS. THE DIFFICULTY IN TREATING DRUG ADDICTION IS COMPOUNDED BY THE HIGH COMORBIDITY WITH OTHER PSYCHIATRIC ILLNESSES, INCLUDING ANXIETY DISORDERS. HERE, WE DEMONSTRATE THAT G9A, AN EPIGENETIC REPRESSOR OF GENE EXPRESSION, ACTING IN THE NUCLEUS ACCUMBENS, A BRAIN REWARD REGION, IS CAPABLE OF INCREASING BOTH ADDICTION- AND ANXIETY-LIKE BEHAVIORS IN RATS. THESE FINDINGS ARE INTRIGUING BECAUSE REPEATED COCAINE EXPOSURE DECREASES G9A IN THIS REGION AND THEREBY ENHANCES EXPRESSION OF CERTAIN ADDICTION-PROMOTING GENES. HOWEVER, OUR RESULTS SUGGEST THAT COUNTERING THIS COCAINE-INDUCED DECREASE IN G9A ACTIVITY ACTUALLY EXACERBATES ADDICTION AND SENSITIVITY TO RELAPSE UNDER STRESSFUL SITUATIONS. 2018 9 1783 20 EFFECT OF AGOMELATINE ON MEMORY DEFICITS AND HIPPOCAMPAL GENE EXPRESSION INDUCED BY CHRONIC SOCIAL DEFEAT STRESS IN MICE. CHRONIC STRESS IS KNOWN TO INDUCE NOT ONLY ANXIETY AND DEPRESSIVE-LIKE PHENOTYPES IN MICE BUT ALSO COGNITIVE IMPAIRMENTS, FOR WHICH THE ACTION OF CLASSICAL ANTIDEPRESSANT COMPOUNDS REMAINS UNSATISFACTORY. IN THIS CONTEXT, WE INVESTIGATED THE EFFECTS OF CHRONIC SOCIAL DEFEAT STRESS (CSDS) ON ANXIETY-, SOCIAL- AND COGNITIVE-RELATED BEHAVIORS, AS WELL AS HIPPOCAMPAL BDNF, SYNAPTIC PLASTICITY MARKERS (PSD-95, SYNAPTOPHYSIN, SPINOPHILIN, SYNAPSIN I AND MAP-2), AND EPIGENETIC MODIFYING ENZYMES (MYST2, HDAC2, HDAC6, MLL3, KDM5B, DNMT3B, GADD45B) GENE EXPRESSION IN C57BL/6J MICE. CSDS FOR 10 DAYS PROVOKED LONG-LASTING ANXIOUS-LIKE PHENOTYPE IN THE OPEN FIELD AND EPISODIC MEMORY DEFICITS IN THE NOVEL OBJECT RECOGNITION TEST. WHILE TOTAL BDNF MRNA LEVEL WAS UNCHANGED, BDNF EXON IV, MAP-2, HDAC2, HDAC6 AND MLL3 GENE EXPRESSION WAS SIGNIFICANTLY DECREASED IN THE CSDS MOUSE HIPPOCAMPUS. IN CSDS MICE TREATED 3 WEEKS WITH 50 MG/KG/D AGOMELATINE, AN ANTIDEPRESSANT WITH MELATONERGIC RECEPTOR AGONIST AND 5-HT(2C) RECEPTOR ANTAGONIST PROPERTIES, THE ANXIOUS-LIKE PHENOTYPE WAS NOT REVERSED, BUT THE TREATMENT SUCCESSFULLY PREVENTED THE COGNITIVE IMPAIRMENTS AND HIPPOCAMPAL GENE EXPRESSION MODIFICATIONS. ALTOGETHER, THESE DATA EVIDENCED THAT, IN MICE, AGOMELATINE WAS EFFECTIVE IN ALLEVIATING STRESS-INDUCED ALTERED COGNITIVE FUNCTIONS, POSSIBLY THROUGH A MECHANISM INVOLVING BDNF SIGNALING, SYNAPTIC PLASTICITY AND EPIGENETIC REMODELING. 2017 10 4299 22 MICRORNA-15B CONTRIBUTES TO DEPRESSION-LIKE BEHAVIOR IN MICE BY AFFECTING SYNAPTIC PROTEIN LEVELS AND FUNCTION IN THE NUCLEUS ACCUMBENS. MAJOR DEPRESSION IS A PREVALENT AFFECTIVE DISORDER CHARACTERIZED BY RECURRENT LOW MOOD. IT PRESUMABLY RESULTS FROM STRESS-INDUCED DETERIORATIONS OF MOLECULAR NETWORKS AND SYNAPTIC FUNCTIONS IN BRAIN REWARD CIRCUITS OF GENETICALLY-SUSCEPTIBLE INDIVIDUALS THROUGH EPIGENETIC PROCESSES. EPIGENETIC REGULATOR MICRORNA-15B INHIBITS NEURONAL PROGENITOR PROLIFERATION AND IS UP-REGULATED IN THE MEDIAL PREFRONTAL CORTEX OF MICE THAT DEMONSTRATE DEPRESSION-LIKE BEHAVIOR, INDICATING THE CONTRIBUTION OF MICRORNA-15 TO MAJOR DEPRESSION. USING A MOUSE MODEL OF MAJOR DEPRESSION INDUCED BY CHRONIC UNPREDICTABLE MILD STRESS (CUMS), HERE WE EXAMINED THE EFFECTS OF MICRORNA-15B ON SYNAPSES AND SYNAPTIC PROTEINS IN THE NUCLEUS ACCUMBENS OF THESE MICE. THE APPLICATION OF A MICRORNA-15B ANTAGOMIR INTO THE NUCLEUS ACCUMBENS SIGNIFICANTLY REDUCED THE INCIDENCE OF CUMS-INDUCED DEPRESSION AND REVERSED THE ATTENUATIONS OF EXCITATORY SYNAPSE AND SYNTAXIN-BINDING PROTEIN 3 (STXBP3A)/VESICLE-ASSOCIATED PROTEIN 1 (VAMP1) EXPRESSION. IN CONTRAST, THE INJECTION OF A MICRORNA-15B ANALOG INTO THE NUCLEUS ACCUMBENS INDUCED DEPRESSION-LIKE BEHAVIOR AS WELL AS ATTENUATED EXCITATORY SYNAPSES AND STXBP3A/VAMP1 EXPRESSION SIMILAR TO THE DOWN-REGULATION OF THESE PROCESSES INDUCED BY THE CUMS. WE CONCLUDE THAT MICRORNA-15B-5P MAY PLAY A CRITICAL ROLE IN CHRONIC STRESS-INDUCED DEPRESSION BY DECREASING SYNAPTIC PROTEINS, INNERVATIONS, AND ACTIVITIES IN THE NUCLEUS ACCUMBENS. WE PROPOSE THAT THE TREATMENT OF ANTI-MICRORNA-15B-5P MAY CONVERT STRESS-INDUCED DEPRESSION INTO RESILIENCE. 2020 11 1315 22 DELTA FOSB MEDIATES EPIGENETIC DESENSITIZATION OF THE C-FOS GENE AFTER CHRONIC AMPHETAMINE EXPOSURE. THE MOLECULAR MECHANISMS UNDERLYING THE TRANSITION FROM RECREATIONAL DRUG USE TO CHRONIC ADDICTION REMAIN POORLY UNDERSTOOD. ONE MOLECULE IMPLICATED IN THIS PROCESS IS DELTAFOSB, A TRANSCRIPTION FACTOR THAT ACCUMULATES IN STRIATUM AFTER REPEATED DRUG EXPOSURE AND MEDIATES SENSITIZED BEHAVIORAL RESPONSES TO PSYCHOSTIMULANTS AND OTHER DRUGS OF ABUSE. THE DOWNSTREAM TRANSCRIPTIONAL MECHANISMS BY WHICH DELTAFOSB REGULATES DRUG-INDUCED BEHAVIORS ARE INCOMPLETELY UNDERSTOOD. WE REPORTED PREVIOUSLY THE CHROMATIN REMODELING MECHANISMS BY WHICH DELTAFOSB ACTIVATES THE EXPRESSION OF CERTAIN GENES; HOWEVER, THE MECHANISMS UNDERLYING DELTAFOSB-MEDIATED GENE REPRESSION REMAIN UNKNOWN. HERE, WE IDENTIFY C-FOS, AN IMMEDIATE EARLY GENE RAPIDLY INDUCED IN STRIATUM AFTER ACUTE PSYCHOSTIMULANT EXPOSURE, AS A NOVEL DOWNSTREAM TARGET THAT IS REPRESSED CHRONICALLY BY DELTAFOSB. WE SHOW THAT ACCUMULATION OF DELTAFOSB IN STRIATUM AFTER CHRONIC AMPHETAMINE TREATMENT DESENSITIZES C-FOS MRNA INDUCTION TO A SUBSEQUENT DRUG DOSE. DELTAFOSB DESENSITIZES C-FOS EXPRESSION BY RECRUITING HISTONE DEACETYLASE 1 (HDAC1) TO THE C-FOS GENE PROMOTER, WHICH, IN TURN, DEACETYLATES SURROUNDING HISTONES AND ATTENUATES GENE ACTIVITY. ACCORDINGLY, LOCAL KNOCK-OUT OF HDAC1 IN STRIATUM ABOLISHES AMPHETAMINE-INDUCED DESENSITIZATION OF THE C-FOS GENE. IN CONCERT, CHRONIC AMPHETAMINE INCREASES HISTONE H3 METHYLATION ON THE C-FOS PROMOTER, A CHROMATIN MODIFICATION ALSO KNOWN TO REPRESS GENE ACTIVITY, AS WELL AS EXPRESSION LEVELS OF THE H3 HISTONE METHYLTRANSFERASE, KMT1A (LYSINE METHYLTRANSFERASE 1A, FORMERLY SUV39H1). THIS STUDY REVEALS A NOVEL EPIGENETIC PATHWAY THROUGH WHICH DELTAFOSB MEDIATES DISTINCT TRANSCRIPTIONAL PROGRAMS THAT MAY ULTIMATELY ALTER BEHAVIORAL PLASTICITY TO CHRONIC AMPHETAMINE EXPOSURE. 2008 12 2826 28 FLUOXETINE EPIGENETICALLY ALTERS THE CAMKIIALPHA PROMOTER IN NUCLEUS ACCUMBENS TO REGULATE DELTAFOSB BINDING AND ANTIDEPRESSANT EFFECTS. CHRONIC SOCIAL DEFEAT STRESS IN MICE PRODUCES A SUSCEPTIBLE PHENOTYPE CHARACTERIZED BY SEVERAL BEHAVIORAL ABNORMALITIES CONSISTENT WITH HUMAN DEPRESSION THAT ARE REVERSED BY CHRONIC BUT NOT ACUTE EXPOSURE TO ANTIDEPRESSANT MEDICATIONS. RECENT WORK IN ADDICTION MODELS DEMONSTRATES THAT THE TRANSCRIPTION FACTOR DELTAFOSB AND PROTEIN KINASE CALMODULIN-DEPENDENT PROTEIN KINASE II (CAMKII) ARE CO-REGULATED IN NUCLEUS ACCUMBENS (NAC), A BRAIN REWARD REGION IMPLICATED IN BOTH ADDICTION AND DEPRESSION MODELS INCLUDING SOCIAL DEFEAT. PREVIOUS WORK HAS ALSO DEMONSTRATED THAT DELTAFOSB IS INDUCED IN NAC AFTER CHRONIC SOCIAL DEFEAT STRESS OR AFTER CHRONIC ANTIDEPRESSANT TREATMENT, WHEREIN IT MEDIATES A PRO-RESILIENCE OR ANTIDEPRESSANT-LIKE PHENOTYPE. HERE, USING CHROMATIN IMMUNOPRECIPITATION ASSAYS, WE FOUND THAT DELTAFOSB BINDS THE CAMKIIALPHA GENE PROMOTER IN NAC AND THAT THIS BINDING INCREASES AFTER MICE ARE EXPOSED TO CHRONIC SOCIAL DEFEAT STRESS. PARADOXICALLY, CHRONIC EXPOSURE TO THE ANTIDEPRESSANT FLUOXETINE REDUCES BINDING OF DELTAFOSB TO THE CAMKIIALPHA PROMOTER AND REDUCES CAMKII EXPRESSION IN NAC, DESPITE THE FACT THAT DELTAFOSB IS INDUCED UNDER THESE CONDITIONS. THESE DATA SUGGEST A NOVEL EPIGENETIC MECHANISM OF ANTIDEPRESSANT ACTION, WHEREBY FLUOXETINE INDUCES SOME CHROMATIN CHANGE AT THE CAMKIIALPHA PROMOTER, WHICH BLOCKS THE DELTAFOSB BINDING. INDEED, CHRONIC FLUOXETINE REDUCES ACETYLATION AND INCREASES LYSINE-9 DIMETHYLATION OF HISTONE H3 AT THE CAMKIIALPHA PROMOTER IN NAC, EFFECTS ALSO SEEN IN DEPRESSED HUMANS EXPOSED TO ANTIDEPRESSANTS. OVEREXPRESSION OF CAMKII IN NAC BLOCKS FLUOXETINE'S ANTIDEPRESSANT EFFECTS IN THE CHRONIC SOCIAL DEFEAT PARADIGM, WHEREAS INHIBITION OF CAMKII ACTIVITY IN NAC MIMICS FLUOXETINE EXPOSURE. THESE FINDINGS SUGGEST THAT EPIGENETIC SUPPRESSION OF CAMKIIALPHA EXPRESSION IN NAC IS BEHAVIORALLY RELEVANT AND OFFER A NOVEL PATHWAY FOR POSSIBLE THERAPEUTIC INTERVENTION IN DEPRESSION AND RELATED SYNDROMES. 2014 13 995 27 CHRONIC STRESS LEADS TO EPIGENETIC DYSREGULATION IN THE NEUROPEPTIDE-Y AND CANNABINOID CB1 RECEPTOR GENES IN THE MOUSE CINGULATE CORTEX. PERSISTENT STRESS TRIGGERS A VARIETY OF MECHANISMS, WHICH MAY ULTIMATELY LEAD TO THE OCCURRENCE OF ANXIETY- AND DEPRESSION-RELATED DISORDERS. EPIGENETIC MODIFICATIONS REPRESENT A MECHANISM BY WHICH CHRONIC STRESS MEDIATES LONG-TERM EFFECTS. HERE, WE ANALYZED BRAIN TISSUE FROM MICE EXPOSED TO CHRONIC UNPREDICTABLE STRESS (CUS), WHICH INDUCED IMPAIRED EMOTIONAL AND NOCICEPTIVE BEHAVIORS. AS ENDOCANNABINOID (ECB) AND NEUROPEPTIDE-Y (NPY) SYSTEMS MODULATE EMOTIONAL PROCESSES, WE HYPOTHESIZED THAT CUS MAY AFFECT THESE SYSTEMS THROUGH EPIGENETIC MECHANISMS. WE FOUND REDUCED NPY EXPRESSION AND NPY TYPE 1 RECEPTOR (NPY1R) SIGNALING, AND DECREASED EXPRESSION OF THE CANNABINOID TYPE 1 RECEPTOR (CB1) IN THE CINGULATE CORTEX OF CUS MICE SPECIFICALLY IN LOW CB1-EXPRESSING NEURONS. EPIGENETIC INVESTIGATIONS REVEALED REDUCED LEVELS OF HISTONE H3K9 ACETYLATION (H3K9AC) ASSOCIATED TO NPY AND CB1 GENES, WHICH MAY REPRESENT A FACTOR DETERMINING THE DYSREGULATION OCCURRING AT EXPRESSION AND SIGNALING LEVEL. CUS MICE ALSO SHOWED INCREASED NUCLEAR PROTEIN LEVELS AND ACTIVITY OF THE HISTONE DEACETYLASE TYPE 2 (HDAC2) IN THE CINGULATE CORTEX AS COMPARED TO CONTROLS. CHRONIC ADMINISTRATION OF URB597, AN INHIBITOR OF ANANDAMIDE DEGRADATION, WHICH IS KNOWN TO INDUCE ANXIOLYSIS IN CUS MICE, REVERSED THE EPIGENETIC CHANGES FOUND IN THE NPY GENE, BUT WAS INEFFECTIVE IN ALLEVIATING THE DYSREGULATION OF NPY AT TRANSCRIPTIONAL AND SIGNALING LEVEL. OUR FINDINGS SUGGEST THAT EPIGENETIC ALTERATIONS IN THE NPY AND CB1 GENES REPRESENT ONE OF THE POTENTIAL MECHANISMS CONTRIBUTING TO THE EMOTIONAL IMBALANCE INDUCED BY CUS IN MICE, AND THAT THE NPY AND ECB SYSTEMS MAY REPRESENT THERAPEUTIC TARGETS FOR THE TREATMENT OF PSYCHOPATHOLOGIES ASSOCIATED WITH OR TRIGGERED BY CHRONIC STRESS STATES. 2017 14 3370 29 HISTONE MODIFICATION OF NEDD4 UBIQUITIN LIGASE CONTROLS THE LOSS OF AMPA RECEPTORS AND COGNITIVE IMPAIRMENT INDUCED BY REPEATED STRESS. STRESS AND THE MAJOR STRESS HORMONE CORTICOSTERONE INDUCE PROFOUND INFLUENCES IN THE BRAIN. ALTERED HISTONE MODIFICATION AND TRANSCRIPTIONAL DYSFUNCTION HAVE BEEN IMPLICATED IN STRESS-RELATED MENTAL DISORDERS. WE PREVIOUSLY FOUND THAT REPEATED STRESS CAUSED AN IMPAIRMENT OF PREFRONTAL CORTEX (PFC)-MEDIATED COGNITIVE FUNCTIONS BY INCREASING THE UBIQUITINATION AND DEGRADATION OF AMPA-TYPE GLUTAMATE RECEPTORS VIA A MECHANISM DEPENDING ON THE E3 UBIQUITIN LIGASE NEDD4. HERE, WE DEMONSTRATED THAT IN PFC OF REPEATEDLY STRESSED RATS, ACTIVE GLUCOCORTICOID RECEPTOR HAD THE INCREASED BINDING TO THE GLUCOCORTICOID RESPONSE ELEMENT OF HISTONE DEACETYLASE 2 (HDAC2) PROMOTER, RESULTING IN THE UPREGULATION OF HDAC2. INHIBITION OR KNOCK-DOWN OF HDAC2 BLOCKED THE STRESS-INDUCED IMPAIRMENT OF SYNAPTIC TRANSMISSION, AMPAR EXPRESSION, AND RECOGNITION MEMORY. FURTHERMORE, WE FOUND THAT, IN STRESSED ANIMALS, THE HDAC2-DEPENDENT DOWNREGULATION OF HISTONE METHYLTRANSFERASE EHMT2 (G9A) LED TO THE LOSS OF REPRESSIVE HISTONE METHYLATION AT THE NEDD4-1 PROMOTER AND THE TRANSCRIPTIONAL ACTIVATION OF NEDD4. THESE RESULTS HAVE PROVIDED AN EPIGENETIC MECHANISM AND A POTENTIAL TREATMENT STRATEGY FOR THE DETRIMENTAL EFFECTS OF CHRONIC STRESS. SIGNIFICANCE STATEMENT: PROLONGED STRESS EXPOSURE CAN INDUCE ALTERED HISTONE MODIFICATION AND TRANSCRIPTIONAL DYSFUNCTION, WHICH MAY UNDERLIE THE PROFOUND INFLUENCE OF STRESS IN REGULATING BRAIN FUNCTIONS. WE REPORT AN IMPORTANT FINDING ABOUT THE EPIGENETIC MECHANISM CONTROLLING THE DETRIMENTAL EFFECTS OF REPEATED STRESS ON SYNAPTIC TRANSMISSION AND COGNITIVE FUNCTION. FIRST, IT HAS REVEALED THE STRESS-INDUCED ALTERATION OF KEY EPIGENETIC REGULATORS HDAC2 AND EHMT2, WHICH DETERMINES THE SYNAPTIC AND BEHAVIORAL EFFECTS OF REPEATED STRESS. SECOND, IT HAS UNCOVERED THE STRESS-INDUCED HISTONE MODIFICATION OF THE TARGET GENE NEDD4, AN E3 LIGASE THAT IS CRITICALLY INVOLVED IN THE UBIQUITINATION AND DEGRADATION OF AMPA RECEPTORS AND COGNITION. THIRD, IT HAS PROVIDED THE EPIGENETIC APPROACH, HDAC2 INHIBITION OR KNOCK-DOWN, TO RESCUE SYNAPTIC AND COGNITIVE FUNCTIONS IN STRESSED ANIMALS. 2016 15 2325 29 EPIGENETIC REGULATION OF HIPPOCAMPAL FOSB EXPRESSION CONTROLS BEHAVIORAL RESPONSES TO COCAINE. DRUG ADDICTION RESULTS IN PART FROM MALADAPTIVE LEARNING, INCLUDING THE FORMATION OF STRONG ASSOCIATIONS BETWEEN THE DRUG AND THE CIRCUMSTANCES OF CONSUMPTION. HOWEVER, DRUG-INDUCED CHANGES IN GENE EXPRESSION UNDERLYING THE SALIENCY OF THESE ASSOCIATIONS REMAIN UNDERSTUDIED. CONSOLIDATION OF EXPLICIT MEMORIES OCCURS WITHIN THE HIPPOCAMPUS, AND WE HAVE SHOWN THAT SPATIAL LEARNING INDUCES EXPRESSION OF THE TRANSCRIPTION FACTOR DELTAFOSB IN HIPPOCAMPUS AND THAT THIS INDUCTION IS CRITICAL FOR LEARNING. DRUGS OF ABUSE ALSO UPREGULATE DELTAFOSB IN HIPPOCAMPUS, BUT THE MECHANISM OF ITS INDUCTION BY COCAINE AND ITS ROLE IN HIPPOCAMPUS-DEPENDENT COCAINE RESPONSES IS UNKNOWN. WE INVESTIGATED DIFFERENCES IN MOUSE DORSAL AND VENTRAL HIPPOCAMPAL DELTAFOSB EXPRESSION IN RESPONSE TO CHRONIC COCAINE, BECAUSE THESE REGIONS APPEAR TO REGULATE DISTINCT COCAINE-RELATED BEHAVIORS. WE FOUND THAT COCAINE-MEDIATED INDUCTION OF DELTAFOSB WAS SUBREGION-SPECIFIC, AND THAT DELTAFOSB TRANSCRIPTIONAL ACTIVITY IN BOTH THE DORSAL AND VENTRAL HIPPOCAMPUS IS NECESSARY FOR COCAINE CONDITIONED PLACE PREFERENCE. FURTHER, WE CHARACTERIZE CHANGES IN HISTONE MODIFICATIONS AT THE FOSB PROMOTER IN HIPPOCAMPUS IN RESPONSE TO CHRONIC COCAINE AND FOUND THAT LOCUS-SPECIFIC EPIGENETIC MODIFICATION IS ESSENTIAL FOR FOSB INDUCTION AND MULTIPLE HIPPOCAMPUS-DEPENDENT BEHAVIORS, INCLUDING COCAINE PLACE PREFERENCE. COLLECTIVELY, THESE FINDINGS SUGGEST THAT EXPOSURE TO COCAINE INDUCES HISTONE MODIFICATION AT THE HIPPOCAMPAL FOSB GENE PROMOTER TO CAUSE DELTAFOSB INDUCTION CRITICAL FOR COCAINE-RELATED LEARNING.SIGNIFICANCE STATEMENT ALTHOUGH COCAINE ADDICTION IS DRIVEN IN PART BY THE FORMATION OF INDELIBLE ASSOCIATIONS BETWEEN THE DRUG AND THE ENVIRONMENT, PARAPHERNALIA, AND CIRCUMSTANCES OF USE, AND ALTHOUGH THIS TYPE OF ASSOCIATIVE LEARNING IS DEPENDENT UPON CHANGES IN GENE EXPRESSION IN A BRAIN REGION CALLED THE HIPPOCAMPUS, THE MECHANISMS BY WHICH COCAINE ALTERS HIPPOCAMPAL GENE EXPRESSION TO DRIVE FORMATION OF THESE ASSOCIATIONS IS POORLY UNDERSTOOD. HERE, WE DEMONSTRATE THAT CHRONIC COCAINE ENGAGES LOCUS-SPECIFIC CHANGES IN THE EPIGENETIC PROFILE OF THE FOSB GENE IN THE HIPPOCAMPUS, AND THAT THESE ALTERATIONS ARE REQUIRED FOR COCAINE-DEPENDENT GENE EXPRESSION AND COCAINE-ENVIRONMENT ASSOCIATIONS. THIS WORK PROVIDES NOVEL INSIGHT INTO ADDICTION ETIOLOGY AND POTENTIAL INROADS FOR THERAPEUTIC INTERVENTION IN COCAINE ADDICTION. 2019 16 3314 24 HIPPOCAMPAL CANNABINOID 1 RECEPTORS ARE MODULATED FOLLOWING COCAINE SELF-ADMINISTRATION IN MALE RATS. COCAINE ADDICTION IS A COMPLEX PATHOLOGY INDUCING LONG-TERM NEUROPLASTIC CHANGES THAT, IN TURN, CONTRIBUTE TO MALADAPTIVE BEHAVIORS. THIS BEHAVIORAL DYSREGULATION IS ASSOCIATED WITH TRANSCRIPTIONAL REPROGRAMMING IN BRAIN REWARD CIRCUITRY, ALTHOUGH THE MECHANISMS UNDERLYING THIS MODULATION REMAIN POORLY UNDERSTOOD. THE ENDOGENOUS CANNABINOID SYSTEM MAY PLAY A ROLE IN THIS PROCESS IN THAT CANNABINOID MECHANISMS MODULATE DRUG REWARD AND CONTRIBUTE TO COCAINE-INDUCED NEURAL ADAPTATIONS. IN THIS STUDY, WE INVESTIGATED WHETHER COCAINE SELF-ADMINISTRATION INDUCES LONG-TERM ADAPTATIONS, INCLUDING TRANSCRIPTIONAL MODIFICATIONS AND ASSOCIATED EPIGENETIC PROCESSES. WE FIRST EXAMINED ENDOCANNABINOID GENE EXPRESSION IN REWARD-RELATED BRAIN REGIONS OF THE RAT FOLLOWING SELF-ADMINISTERED (0.33 MG/KG INTRAVENOUS, FR1, 10 DAYS) COCAINE INJECTIONS. INTERESTINGLY, WE FOUND INCREASED CNR1 EXPRESSION IN SEVERAL STRUCTURES, INCLUDING PREFRONTAL CORTEX, NUCLEUS ACCUMBENS, DORSAL STRIATUM, HIPPOCAMPUS, HABENULA, AMYGDALA, LATERAL HYPOTHALAMUS, VENTRAL TEGMENTAL AREA, AND ROSTROMEDIAL TEGMENTAL NUCLEUS, WITH MOST PRONOUNCED EFFECTS IN THE HIPPOCAMPUS. ENDOCANNABINOID LEVELS, MEASURED BY MASS SPECTROMETRY, WERE ALSO ALTERED IN THIS STRUCTURE. CHROMATIN IMMUNOPRECIPITATION FOLLOWED BY QPCR IN THE HIPPOCAMPUS REVEALED THAT TWO ACTIVATING HISTONE MARKS, H3K4ME3 AND H3K27AC, WERE ENRICHED AT SPECIFIC ENDOCANNABINOID GENES FOLLOWING COCAINE INTAKE. TARGETING CB1 RECEPTORS USING CHROMOSOME CONFORMATION CAPTURE, WE HIGHLIGHTED SPATIAL CHROMATIN RE-ORGANIZATION IN THE HIPPOCAMPUS, AS WELL AS IN THE NUCLEUS ACCUMBENS, SUGGESTING THAT DESTABILIZATION OF THE CHROMATIN MAY CONTRIBUTE TO NEURONAL RESPONSES TO COCAINE. OVERALL, OUR RESULTS HIGHLIGHT A KEY ROLE FOR THE HIPPOCAMPUS IN COCAINE-INDUCED PLASTICITY AND BROADEN THE UNDERSTANDING OF NEURONAL ALTERATIONS ASSOCIATED WITH ENDOCANNABINOID SIGNALING. THE LATTER SUGGESTS THAT EPIGENETIC MODIFICATIONS CONTRIBUTE TO MALADAPTIVE BEHAVIORS ASSOCIATED WITH CHRONIC DRUG USE. 2022 17 3154 24 GLUN2B/CAMKII MEDIATES CFA-INDUCED HYPERALGESIA VIA HDAC4-MODIFIED SPINAL COX2 TRANSCRIPTION. HISTONE DEACETYLASE 4 (HDAC4), WHICH ACTIVELY SHUTTLES BETWEEN THE NUCLEUS AND CYTOPLASM, IS AN ATTRACTIVE CANDIDATE FOR A REPRESSOR MECHANISM IN EPIGENETIC MODIFICATION. HOWEVER, THE POTENTIAL ROLE OF HDAC4-DEPENDENT EPIGENETICS IN THE NEURAL PLASTICITY UNDERLYING THE DEVELOPMENT OF INFLAMMATORY PAIN HAS NOT BEEN WELL ESTABLISHED. BY INJECTING COMPLETE FREUND'S ADJUVANT (CFA) INTO THE HIND-PAW OF SPRAGUE-DAWLEY RATS (200-250 G), WE FOUND ANIMALS DISPLAYED BEHAVIORAL HYPERALGESIA WAS ACCOMPANIED WITH HDAC4 PHOSPHORYLATION AND CYTOPLASMIC REDISTRIBUTION IN THE DORSAL HORN NEURONS. CYTOPLASMIC HDAC4 RETENTION LED TO ITS UNCOUPLING WITH THE COX2 PROMOTER, HENCE PROMPTING SPINAL COX2 TRANSCRIPTION AND EXPRESSION IN THE DORSAL HORN. MOREOVER, THE GLUN2B-BEARING N-METHYL-D-ASPARTATE RECEPTOR (GLUN2B-NMDAR)/CALMODULIN-DEPENDENT PROTEIN KINASE II (CAMKII) ACTED AS AN UPSTREAM CASCADE TO FACILITATE HDAC4 PHOSPHORYLATION/REDISTRIBUTION-ASSOCIATED SPINAL COX2 EXPRESSION AFTER INFLAMMATORY INSULTS. THE RESULTS OF THIS PILOT STUDY DEMONSTRATED THAT THE DEVELOPMENT AND/OR MAINTENANCE OF INFLAMMATORY PAIN INVOLVED THE SPINAL HDAC4-DEPENDENT EPIGENETIC MECHANISMS. OUR FINDINGS OPEN UP A NEW AVENUE FOR THE DEVELOPMENT OF A NOVEL MEDICAL STRATEGY FOR THE RELIEF OF INFLAMMATORY PAIN. 2018 18 2477 24 EPIGENETIC UPREGULATION OF CDK5 IN THE DORSAL HORN CONTRIBUTES TO NEUROPATHIC PAIN IN RATS. NUMEROUS REPORTS HAVE SHOWN THAT CYCLIN-DEPENDENT KINASE 5 (CDK5), A PROLINE-DIRECTED SERINE/THREONINE KINASE, CRITICALLY CONTRIBUTES TO THE INDUCTION AND MAINTENANCE OF CHRONIC PAIN INDUCED BY PERIPHERAL INFLAMMATION AND NERVE INJURY. RECENT EVIDENCE HAS ALSO SUGGESTED THE CRITICAL ROLE OF AN EPIGENETIC MECHANISM IN THE SETTING OF CHRONIC PAIN. THE PRESENT STUDY AIMS TO ELUCIDATE THE CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN (CREB)-MEDIATED UPREGULATION OF CDK5 AND ITS FUNCTIONAL SIGNIFICANCE IN RATS WITH NEUROPATHIC PAIN INDUCED BY CHRONIC CONSTRICTION INJURY (CCI) IN THE SCIATIC NERVE. SIGNIFICANTLY INCREASED EXPRESSION OF CDK5 WAS OBSERVED IN THE DORSAL HORN OF RATS WITH CCI, AND INTRATHECAL DELIVERY OF CDK5 INHIBITOR ROSCOVITINE SIGNIFICANTLY ATTENUATED THE MECHANICAL ALLODYNIA IN THESE RATS. PHOSPHORYLATION OF CREB AND ITS OCCUPANCY IN THE CDK5 PROMOTER REGION WAS ALSO INCREASED IN THE DORSAL HORN, WHICH LED TO INCREASED HISTONE H4 ACETYLATION IN THE CDK5 PROMOTER REGION AND THE UPREGULATED TRANSCRIPTION OF CDK5. INHIBITION OF CREB ACTIVITY ATTENUATED THE UPREGULATION OF CDK5 AND ALLEVIATED THE MECHANICAL ALLODYNIA IN RATS WITH CCI. THESE RESULTS DEMONSTRATED A CREB-MEDIATED EPIGENETIC UPREGULATION OF CDK5 IN THE DORSAL HORN, WHICH CRITICALLY CONTRIBUTED TO THE MAINTENANCE OF PAINFUL BEHAVIOR IN THE RATS WITH NEUROPATHIC PAIN. 2014 19 2839 23 FOSB INDUCTION IN NUCLEUS ACCUMBENS BY COCAINE IS REGULATED BY E2F3A. THE TRANSCRIPTION FACTOR DELTAFOSB HAS BEEN PROPOSED AS A MOLECULAR SWITCH FOR THE TRANSITION FROM CASUAL, VOLITIONAL DRUG USE INTO A CHRONICALLY ADDICTED STATE, BUT THE UPSTREAM REGULATORY MECHANISMS GOVERNING DELTAFOSB EXPRESSION ARE INCOMPLETELY UNDERSTOOD. IN THIS STUDY, WE FIND A NOVEL REGULATORY ROLE FOR THE TRANSCRIPTION FACTOR E2F3, RECENTLY IMPLICATED IN TRANSCRIPTIONAL REGULATION BY COCAINE, IN CONTROLLING DELTAFOSB INDUCTION IN THE MOUSE NUCLEUS ACCUMBENS (NAC) FOLLOWING COCAINE ADMINISTRATION. WE FIND THAT AN E2F CONSENSUS SEQUENCE 500 BP UPSTREAM OF THE FOSB TRANSCRIPTION START SITE IS ENRICHED FOR E2F3 SPECIFICALLY OVER OTHER E2F ISOFORMS. WE FURTHER CONCLUDE THAT DELTAFOSB EXPRESSION IS REGULATED SPECIFICALLY BY E2F3A, NOT E2F3B, THAT E2F3A EXPRESSION IS SPECIFIC TO D1 RECEPTOR-EXPRESSING MEDIUM SPINY NEURONS, AND THAT E2F3A OVEREXPRESSION IN NAC RECAPITULATES THE INDUCTION OF FOSB AND DELTAFOSB MRNA EXPRESSION OBSERVED AFTER CHRONIC COCAINE EXPOSURE. E2F3A KNOCKDOWN IN NAC DOES NOT ABOLISH DELTAFOSB INDUCTION BY COCAINE, A RESULT CONSISTENT WITH PREVIOUSLY PUBLISHED DATA SHOWING THAT SINGULAR KNOCKDOWN OF UPSTREAM REGULATORS OF DELTAFOSB IS INSUFFICIENT TO BLOCK COCAINE-INDUCED EXPRESSION. FINALLY, TO ELUCIDATE POTENTIAL COMBINATORIAL EPIGENETIC MECHANISMS INVOLVED IN E2F3A'S REGULATION OF FOSB, WE EXPLORE H3K4ME3 ENRICHMENT AT THE FOSB PROMOTER AND FIND THAT IT IS NOT ENHANCED BY E2F3A OVEREXPRESSION, SUGGESTING THAT IT MAY INSTEAD BE A PRE-EXISTING PERMISSIVE MARK ALLOWING FOR E2F3A TO INTERACT WITH FOSB. TOGETHER, THESE FINDINGS SUPPORT A ROLE FOR E2F3A AS A NOVEL, UPSTREAM REGULATOR OF THE ADDICTION-MEDIATING TRANSCRIPTION FACTOR DELTAFOSB IN NAC. 2019 20 69 23 A MEDIAL PREFRONTAL CORTEX-NUCLEUS ACUMENS CORTICOTROPIN-RELEASING FACTOR CIRCUITRY FOR NEUROPATHIC PAIN-INCREASED SUSCEPTIBILITY TO OPIOID REWARD. RECENT STUDIES HAVE SHOWN THAT PERSISTENT PAIN FACILITATES THE RESPONSE TO MORPHINE REWARD. HOWEVER, THE CIRCUIT MECHANISM UNDERLYING THIS PROCESS REMAINS AMBIGUOUS. IN THIS STUDY, USING CHRONIC CONSTRICTION INJURY (CCI) OF THE SCIATIC NERVE IN MICE, WE FOUND THAT PERSISTENT NEUROPATHIC PAIN REDUCED THE MINIMUM NUMBER OF MORPHINE CONDITIONING SESSIONS REQUIRED TO INDUCE CONDITIONED PLACE PREFERENCE (CPP) BEHAVIOR. THIS DOSE OF MORPHINE HAD NO EFFECT ON THE PAIN THRESHOLD. IN THE MEDIAL PREFRONTAL CORTEX (MPFC), WHICH IS INVOLVED IN BOTH PAIN AND EMOTION PROCESSING, CORTICOTROPIN-RELEASING FACTOR (CRF) EXPRESSING NEURONAL ACTIVITY WAS INCREASED IN CCI MICE. CHEMOGENETIC INHIBITION OF MPFC CRF NEURONS REVERSED CCI-INDUCED MORPHINE CPP FACILITATION. FURTHERMORE, THE NUCLEUS ACUMENS (NAC) RECEIVED MPFC CRF FUNCTIONAL PROJECTIONS THAT EXERTED EXCITATORY EFFECTS ON NAC NEURONS. OPTOGENETIC INHIBITION OF MPCF NEURONAL TERMINALS OR LOCAL INFUSION OF THE CRF RECEPTOR 1 (CRFR1) ANTAGONIST IN THE NAC RESTORED THE EFFECTS OF NEUROPATHIC PAIN ON MORPHINE-INDUCED CPP BEHAVIOR, BUT NOT IN NORMAL MICE. ON A MOLECULAR LEVEL, IN CCI MICE, CRFR1 PROTEIN EXPRESSION WAS INCREASED IN THE NAC BY A HISTONE DIMETHYLTRANSFERASE G9A-MEDIATED EPIGENETIC MECHANISM. LOCAL G9A KNOCKDOWN INCREASED THE EXPRESSION OF CRFR1 AND MIMICKED CCI-INDUCED HYPERSENSITIVITY TO ACQUIRING MORPHINE CPP. TAKEN TOGETHER, THESE FINDINGS DEMONSTRATE A PREVIOUSLY UNKNOWN AND SPECIFIC MPFC CRF ENGAGEMENT OF NAC NEURONAL CIRCUITS, THE SENSITIZATION OF WHICH FACILITATES BEHAVIORAL RESPONSES TO MORPHINE REWARD IN NEUROPATHIC PAIN STATES VIA CRFR1S. 2018